| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/26/2003 | EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals |
| 02/26/2003 | EP0436717B1 System for use in a method of therapeutic or diagnostic treatment |
| 02/25/2003 | US6525080 Thiazoline acid derivatives |
| 02/25/2003 | US6524823 Vasopermeability-enhancing conjugates |
| 02/25/2003 | US6524554 Radiopharmaceuticals comprised of one to three pentapeptides attached to metal chelator or bonding moiety, to which is attached radioisotope, optionally further comprising linking group between peptides and chelator; bind to tuftsin receptors |
| 02/25/2003 | US6524553 A compound, comprising: a targeting moiety and a chelator, wherein the targeting moiety is bound to the chelator, is a qinolone nonpeptide, and binds to a receptor that is upregulated during angiogenesis |
| 02/25/2003 | US6524552 Contrast agents |
| 02/25/2003 | US6524232 Method for radioactive stent delivery |
| 02/20/2003 | WO2003014158A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 02/20/2003 | WO2003014155A2 Labelled conjugates of p17 protein and their use in aids diagnosis |
| 02/20/2003 | WO2003013617A2 Conjugates of macrocyclic metal complexes with biomolecules and the utilization thereof for producing agents for use in nmr diagnosis and radiodiagnosis and radiotherapy |
| 02/20/2003 | WO2003013346A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 02/20/2003 | WO2002067998A3 Devices and methods for the treatment of cancer |
| 02/20/2003 | US20030036794 Coated implantable medical device |
| 02/20/2003 | US20030036699 Methods and systems which use annexin for bioprofiling body lumen |
| 02/20/2003 | US20030036652 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4'-piperidines |
| 02/20/2003 | US20030035802 Angiogenosis inhibitors; antitumor, anticancer agents |
| 02/20/2003 | US20030035772 Immobilization of strontium, elution of rubidium in situ; diagnosis, imaging |
| 02/20/2003 | CA2456881A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 02/20/2003 | CA2453214A1 Conjugates of macrocyclic metal complexes with biomolecules and the utilization thereof for producing agents for use in nmr diagnosis and radiodiagnosis and radiotherapy |
| 02/20/2003 | CA2452478A1 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 02/19/2003 | EP1283842A1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation |
| 02/19/2003 | EP1283729A2 Tc and re carbonyl complexes for pertechnetate and perrhenate |
| 02/19/2003 | EP1283728A2 Contrast agents |
| 02/19/2003 | EP1283719A2 Apoptotic agents |
| 02/19/2003 | EP1283707A1 Polymerizable compositions and methods of use |
| 02/19/2003 | EP1283674A2 Therapy of proliferative disorders by direct irradiation of cell nuclei with tritiated nuclear targeting agents |
| 02/18/2003 | US6521652 Thiazoline acid derivatives |
| 02/18/2003 | US6521210 Diagnosing a malignancy in in situ tissue. |
| 02/13/2003 | WO2003012072A2 Monoclonal antibodies to activated erbb family members and methods of use thereof |
| 02/13/2003 | WO2003011869A1 Radioligands and their use for identifying potassium channel modulators |
| 02/13/2003 | WO2003011345A1 Lipid constructs as therapeutic and imaging agents |
| 02/13/2003 | WO2003011342A2 Targeted polymeric delivery systems |
| 02/13/2003 | WO2003011284A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| 02/13/2003 | WO2003011020A1 Imaging marker transgenes |
| 02/13/2003 | WO2002096948A9 Engineered tetravalent antibodies and methods of use |
| 02/13/2003 | WO2002078638A3 Morpholino imaging and therapy |
| 02/13/2003 | WO2002072011A3 Stabilized therapeutic and imaging agents |
| 02/13/2003 | WO2002067761A3 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 02/13/2003 | WO2002062810A3 Linkable sialyl lewis x analogs |
| 02/13/2003 | WO2002040092A3 Directional energy emitting implant |
| 02/13/2003 | WO2002006515A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/13/2003 | WO2001097863A8 PREPARATIONS FOR MEASURING GASTRIC pH VALUE AND METHOD OF MEASURING GASTRIC pH VALUE BY USING THE SAME |
| 02/13/2003 | US20030033616 Imaging marker transgenes |
| 02/13/2003 | US20030032799 For cancer treatment |
| 02/13/2003 | US20030031669 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 02/13/2003 | US20030031665 Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 02/13/2003 | CA2455856A1 Targeted polymeric delivery systems |
| 02/13/2003 | CA2455598A1 Lipid constructs as therapeutic and imaging agents |
| 02/13/2003 | CA2452743A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| 02/12/2003 | EP1283216A1 Somatostatin analogues binding to all somatostatin receptor subtypes and their use |
| 02/12/2003 | EP1283060A1 Preparations for diagnosing infection with helicobacter pylori |
| 02/12/2003 | EP1283059A2 Therapeutic conjugates of toxins and drugs |
| 02/12/2003 | EP1282700A1 Neuronal serine-threonine protein kinase |
| 02/12/2003 | EP1282631A1 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents |
| 02/12/2003 | EP0841953B1 Method and apparatus for interstitial radiation of the prostate gland |
| 02/12/2003 | CN1101183C Sustained release and implantation type mitomycin medicine and method for preparing same |
| 02/11/2003 | US6518061 Interleukin-13 (IL-13); Delivery of a modified Pseudomonas exotoxin (effector molecule), attached to an interleukin, to tumor cells bearing interleukin receptors; antitumor agent |
| 02/11/2003 | US6517814 Tetraaza or hexaaza tricylic derivatives or salts containing radionuclide; useful as x-ray or MRI contrast agent |
| 02/11/2003 | US6517811 Compounds for cancer imaging and therapy |
| 02/11/2003 | US6517810 Palliation of bone pain due to cancer by the administration of a tin stannic (Sn+4) chelate complex |
| 02/11/2003 | US6517809 Using a breath test; vehicle containing a sugar is powder or granules, coating vehicle with an isotope-labeled urea and encapsulating the coated vehicle in gelatin |
| 02/11/2003 | CA2216851C Radiolabeled peptides for diagnosis and therapy |
| 02/07/2003 | WO2002014309A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 02/07/2003 | CA2418790A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof |
| 02/06/2003 | WO2003010199A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 02/06/2003 | WO2003010198A1 Identification of specific tumour antigens by selection of cdna libraries with sera and use of said antigens in diagnostic techniques |
| 02/06/2003 | WO2003010175A2 Radiolabeled neuropeptide y y5 receptor antagonists |
| 02/06/2003 | WO2003009874A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |
| 02/06/2003 | WO2003009804A2 Conformationally constrained parathyroid hormone (pth) analogs |
| 02/06/2003 | WO2002016965A3 Radioactive emission detector |
| 02/06/2003 | WO2001066139A9 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell |
| 02/06/2003 | US20030028244 Coated implantable medical device |
| 02/06/2003 | US20030028243 Coated implantable medical device |
| 02/06/2003 | US20030027302 Ligand for use in radioimmunotherapy |
| 02/06/2003 | US20030026804 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 02/06/2003 | US20030026764 Administering antibodies; anticancer agents |
| 02/06/2003 | CA2454784A1 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 02/06/2003 | CA2453106A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |
| 02/05/2003 | EP1280923A2 14094, a human trypsin family member and uses thereof |
| 02/05/2003 | EP1280559A2 Acylated cyclodextrin guest inclusion complexes |
| 02/05/2003 | CN1394599A Preparation method of medicinal antimony sulfide nano colloidal particles |
| 02/05/2003 | CN1100767C Macrocyclic metal complex carboxylic acids, use and method for production thereof |
| 02/05/2003 | CN1100543C 聚维酮碘膜剂 Povidone iodine agent |
| 02/04/2003 | US6515131 Imaging mammal brain tissue via administering technetium, piperidine derivative complex |
| 02/04/2003 | US6515112 For use in diagnosis and therapy |
| 02/04/2003 | US6515017 Polyamino acid conjugated paclitaxel or docetaxel have increased water solubility, efficacy and accumulation within a tumor |
| 02/04/2003 | US6514193 Method of administering a therapeutically active substance |
| 01/30/2003 | WO2003008394A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents |
| 01/30/2003 | WO2003008390A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 01/30/2003 | WO2003007978A1 Alpha-fetoprotein peptides and uses thereof |
| 01/30/2003 | WO2002066075A3 Biotin-derivatives and their conjugates with chelating agents |
| 01/30/2003 | US20030023090 Used as imaging or pharmaceutical agents, in the diagnosis and therapy of drug addiction, depression, anorexia and neurodegenerative diseases |
| 01/30/2003 | US20030023050 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 01/30/2003 | US20030021792 Quantitative analysis; immunosuppressants, anticoagulants |
| 01/30/2003 | US20030021781 Administering antibodies |
| 01/30/2003 | US20030021779 Immunology response; monoclonal antibodies |
| 01/30/2003 | US20030021749 Treatment of cancer and other diseases by administration of positron-emitting radiopharmaceuticals |
| 01/29/2003 | EP1278830A2 Identification and uses of a hyaluronan receptor |
| 01/29/2003 | EP1278766A2 Polynucleotides for diagnosing mammary gland cancer |